Immunofluorescence Assays Market Report
Immunofluorescence Assays Market Trends, Dynamics & Market Insights See less
Immunofluorescence Assays Market Trends, Dynamics & Market Insights
Immunofluorescence Assays Market, By Product (Reagents and Kits, Instruments, Consumables & Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Others) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global immunofluorescence assays market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Immunofluorescence Assays Market, By Product (Reagents and Kits, Instruments, Consumables & Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Others) and Region ...
The Immunofluorescence Assays Market is estimated to grow from USD 2.5 billion in 2020 to USD 3.6 billion by 2026 at a healthy CAGR of 6.3% during the forecast period.
Immunofluorescence is a light microscopy method with a fluorescence microscope, which is primarily used on microbiological samples. This technique employs the sensitivity of antibodies to their antigen to guide fluorescent dyes to specific biomolecule targets inside a cell, enabling visualization of the target molecule's distribution within the sample.
Key players operating in the immunofluorescence assays market are-
The growing prevalence of chronic and infectious diseases such as rheumatoid arthritis, cancer, Alzheimer’s, HIV AIDS, and Parkinson’s are likely to augment the immunofluorescence assay market in the coming years. Moreover, the rising R&D spending & healthcare expenditure further boost the market growth. However, the high cost of assay kits and screening instruments is anticipated to hinder the industry growth. Nevertheless, the developing economies of Brazil, China, and India are expected to offer potential growth opportunities in the following years.
Based on type, the market has been classified into indirect immunofluorescence and direct immunofluorescence. The indirect immunofluorescence segment accounted for a substantial market share in 2020. The benefits of indirect immunofluorescence are high sensitivity and easy to change signal color based on changing the second antibody which can get commercially. The labeled second antibodies are easily obtained. Secondary antibodies are relatively cheaper than primary antibodies, which further boosts the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to favorable government initiatives, established healthcare infrastructure, and the high prevalence of infectious diseases and cancer in the region, which is likely to boost regional growth. Moreover, beneficial government initiatives and a rise in the number of research partnerships further proliferates regional growth.
The COVID-19 outbreak positively influenced the growth of the immunofluorescence assays market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. The COVID-19 pandemic has increased the demand for immunofluorescence assays as people are consuming immunity-booster products to increase immunity to prevent the transmission of coronavirus around the globe. Hence, several manufacturers are trying to develop new products to keep up with the high demand, thus boosting the market growth.
Here is the list of the group of customers that the immunofluorescence assays market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
The immunofluorescence assays market is expected to witness an impressive growth of 6.3% CAGR in the coming years.
Thermo Fisher Scientific Inc. (US), Inova Diagnostics, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abcam (UK), PerkinElmer Inc. (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), and Danaher Corporation (US) are among the key players in the immunofluorescence assays market.
The immunofluorescence assays market size is expected to reach USD 3.6 billion in the foreseeable future.
Indirect immunofluorescence segment accounted for a substantial share in the immunofluorescence assays market in 2020.
North America is expected to remain dominant in the immunofluorescence assays market in the next five years.
Immunofluorescence Assays distributors, Immunofluorescence Assays suppliers, Immunofluorescence Assays manufacturers, Hospitals, Government bodies are the target audience in the immunofluorescence assays market.